Published in Lancet on May 27, 1978
Total artificial heart in two-staged cardiac transplantation. Cardiovasc Dis (1981) 1.66
Total circulatory support with an LVAD in an adolescent with a previous Fontan procedure. Tex Heart Inst J (2005) 1.58
Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg (1995) 1.56
The role of assist devices in managing low cardiac output. Cardiovasc Dis (1981) 0.83
The HeartMate left ventricular assist system. Overview and 12-year experience. Tex Heart Inst J (1998) 0.83
Heart transplantation: challenges facing the field. Cold Spring Harb Perspect Med (2014) 0.79
UTILIZATION OF HAND-HELD PROGRAMMABLE CALCULATORS FOR RAPID BEDSIDE COMPUTATION OF PHYSIOLOGIC-PHARMACOLOGIC VARIABLES AND PROGNOSTIC INDICES DURING MECHANICAL CIRCULATORY SUPPORT. Cardiovasc Dis (1978) 0.78
Combined heart and kidney transplantation: what is the appropriate surgical sequence? Interact Cardiovasc Thorac Surg (2013) 0.75
Combined cardio-renal transplantation (CCRT) from the same donor: report of two cases and review of the literature. Ann R Coll Surg Engl (2001) 0.75
ULTRASTRUCTURAL ANALYSES OF STONE HEART SYNDROME AT ONSET AND SIX DAYS LATER FOLLOWING TOTAL SUPPORT OF THE CIRCULATION WITH A PARTIAL ARTIFICIAL HEART OR LEFT VENTRICULAR ASSIST DEVICE (ALVAD). Cardiovasc Dis (1979) 0.75
SEQUENTIAL ELECTROCARDIOGRAPHIC ANALYSIS OF STONE HEART SYNDROME IN A PATIENT SUPPORTED SIX DAYS WITH AN ABDOMINAL LEFT VENTRICULAR ASSIST DEVICE (ALVAD). Cardiovasc Dis (1979) 0.75
RIGHT AND LEFT VENTRICULAR HEMODYNAMIC INDICES AS PREDICTORS OF THE NEED FOR AND OUTCOME OF POST-CARDIOTOMY MECHANICAL INTRAAORTIC BALLOON PUMP SUPPORT. Cardiovasc Dis (1979) 0.75
Current methods for circulatory support. Tex Heart Inst J (1994) 0.75
Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients. Pediatr Transplant (2017) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Identifying predictors of high quality care in English general practice: observational study. BMJ (2001) 9.34
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Surgical management of aneurysms of the ascending aorta. Including those associated with aortic valvular incompetence. Surg Clin North Am (1966) 6.84
Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect Immun (1994) 5.56
Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective. A rebuttal. J Thorac Cardiovasc Surg (2003) 5.03
Sinus of Valsalva aneurysm or fistula: management and outcome. Ann Thorac Surg (1999) 4.78
Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun (1997) 3.71
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J (2004) 3.70
Primary cardiac sarcomas. Ann Thorac Surg (1991) 3.61
Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun (1985) 3.58
A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol (1999) 3.48
Congenital malformations of the coronary arteries: the Texas Heart Institute experience. Ann Thorac Surg (1992) 3.31
Cloning of the chromosomal determinants encoding hemolysin production and mannose-resistant hemagglutination in Escherichia coli. J Bacteriol (1982) 3.28
Salvage of infected left ventricular assist device with antibiotic beads. Plast Reconstr Surg (2014) 3.28
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation (2012) 3.24
Surgical management of 56 patients with congenital coronary artery fistulas. Ann Thorac Surg (1983) 3.08
Isolation and characterization of the alpha-sialyl-beta-2,3-galactosyl-specific adhesin from fimbriated Escherichia coli. Proc Natl Acad Sci U S A (1987) 2.91
Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J Bacteriol (2000) 2.78
The ASA classification of physical status--a recapitulation. Anesthesiology (1978) 2.65
Large, unstable inserts in the chromosome affect virulence properties of uropathogenic Escherichia coli O6 strain 536. J Bacteriol (1986) 2.65
Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro (1976) 2.65
Regulation of sigmaB-dependent transcription of sigB and asp23 in two different Staphylococcus aureus strains. Mol Gen Genet (1999) 2.62
Spontaneous deletions and flanking regions of the chromosomally inherited hemolysin determinant of an Escherichia coli O6 strain. J Bacteriol (1983) 2.61
Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice. Infect Immun (1983) 2.60
Metabolic gene expression in fetal and failing human heart. Circulation (2001) 2.59
Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother (2000) 2.55
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol (1969) 2.53
Resuscitation of viable but nonculturable Legionella pneumophila Philadelphia JR32 by Acanthamoeba castellanii. Appl Environ Microbiol (1997) 2.45
A molecular phylogeny of Phytophthora and related oomycetes. Fungal Genet Biol (2000) 2.42
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34
Surgical treatment of cardiac tumors: a 25-year experience. Ann Thorac Surg (1990) 2.34
Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli. Infect Immun (1983) 2.26
Gene clusters encoding the cytotoxic necrotizing factor type 1, Prs-fimbriae and alpha-hemolysin form the pathogenicity island II of the uropathogenic Escherichia coli strain J96. FEMS Microbiol Lett (1995) 2.25
Sporadic occurrence of zoonotic swine influenza virus infections. J Clin Microbiol (1984) 2.24
Origin of a new Phytophthora pathogen through interspecific hybridization. Proc Natl Acad Sci U S A (1999) 2.19
Salt extraction of soluble HL-A antigens. Science (1971) 2.18
Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg (1989) 2.17
Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology (1985) 2.14
Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun (1996) 2.13
Extracranial carotid artery aneurysms: Texas Heart Institute experience. J Vasc Surg (2000) 2.07
Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg (1992) 2.06
Virulence patterns and long-range genetic mapping of extraintestinal Escherichia coli K1, K5, and K100 isolates: use of pulsed-field gel electrophoresis. Infect Immun (1991) 2.02
Characterization of the sigma(B) regulon in Staphylococcus aureus. J Bacteriol (2000) 2.00
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail (2005) 1.99
Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping. Methods of scoring and classification, with implications for left ventricular assist device utilization. J Thorac Cardiovasc Surg (1977) 1.96
Complete resection of a right atrial intracavitary metastatic melanoma. Ann Thorac Surg (1996) 1.95
Quality assessment for three common conditions in primary care: validity and reliability of review criteria developed by expert panels for angina, asthma and type 2 diabetes. Qual Saf Health Care (2002) 1.89
Pulsed field electrophoresis of genomic restriction fragments for the detection of nosocomial Legionella pneumophila in hospital water supplies. J Clin Microbiol (1991) 1.89
S-Fimbria-encoding determinant sfa(I) is located on pathogenicity island III(536) of uropathogenic Escherichia coli strain 536. Infect Immun (2001) 1.89
Dysrhythmias after Mustard's operation for transposition of the treat arteries. Am J Cardiol (1972) 1.89
Multiple copies of hemolysin genes and associated sequences in the chromosomes of uropathogenic Escherichia coli strains. J Bacteriol (1984) 1.87
A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages. Infect Immun (1999) 1.86
Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation (1985) 1.83
Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity. Mol Microbiol (1992) 1.83
Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect Immun (2001) 1.82
Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest (1988) 1.82
On the safety of radial artery cannulation. Anesthesiology (1983) 1.81
Ascending aorta-abdominal aorta bypass: indications, technique, and report of 12 patients. Ann Thorac Surg (1977) 1.73
Late embolization of prosthetic mitral valve occluder with survival following reoperation. Ann Thorac Surg (1975) 1.73
tRNA genes and pathogenicity islands: influence on virulence and metabolic properties of uropathogenic Escherichia coli. Mol Microbiol (1995) 1.72
Definitive surgical treatment of anomalous origin of left coronary artery from pulmonary artery: indications and results. J Thorac Cardiovasc Surg (1966) 1.71
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Coronary artery bypass for unsuccessful percutaneous transluminal coronary angioplasty. J Thorac Cardiovasc Surg (1984) 1.71
Common molecular mechanisms of symbiosis and pathogenesis. Trends Microbiol (2000) 1.71
Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect Immun (1986) 1.70
Transplantation antigens. Adv Immunol (1970) 1.70
Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother (1998) 1.70
Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion (1999) 1.69
Extension of donor criteria in cardiac transplantation: surgical risk versus supply-side economics. Ann Thorac Surg (1990) 1.69
First permanent implant of the Jarvik 2000 Heart. Lancet (2000) 1.68
Genetic aspects of Escherichia coli virulence. Microb Pathog (1994) 1.68
Pulsed-field gel electrophoresis of genomic restriction fragments as a tool for the epidemiological analysis of Staphylococcus aureus and coagulase-negative staphylococci. FEMS Microbiol Lett (1992) 1.67
Ischemic contracture of the heart: "stone heart". Am J Cardiol (1972) 1.67
Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med (1989) 1.67
Curli fibers mediate internalization of Escherichia coli by eukaryotic cells. Infect Immun (2001) 1.66
Pathogenicity islands: the tip of the iceberg. Microbes Infect (2001) 1.65
Risk factors for cardiac operations in adult Jehovah's Witnesses. Ann Thorac Surg (1991) 1.65
Detection system for Escherichia coli-specific virulence genes: absence of virulence determinants in B and C strains. Appl Environ Microbiol (1997) 1.64
Bedside right ventricular assist device removal in the conscious patient. Ann Thorac Surg (2007) 1.63
Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion. JAMA (1977) 1.63
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Oncogene (2012) 1.62
Cardiac transplantation for advanced acquired heart disease. J Cardiovasc Surg (Torino) (1969) 1.62
Expression of a chromosomally integrated, single-copy GFP gene in Candida albicans, and its use as a reporter of gene regulation. Mol Gen Genet (1998) 1.61